Medpace Holdings Price to Book Ratio 2014-2025 | MEDP
Historical price to book ratio values for Medpace Holdings (MEDP) over the last 10 years. The current price to book ratio for Medpace Holdings as of February 09, 2026 is 56.42.
| Medpace Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-10 | 446.05 | 42.79 | |
| 2025-09-30 | 514.16 | $10.42 | 49.32 |
| 2025-06-30 | 313.86 | $6.14 | 51.15 |
| 2025-03-31 | 304.69 | $19.90 | 15.31 |
| 2024-12-31 | 332.23 | $26.95 | 12.33 |
| 2024-09-30 | 333.80 | $28.36 | 11.77 |
| 2024-06-30 | 411.85 | $24.63 | 16.72 |
| 2024-03-31 | 404.15 | $21.67 | 18.65 |
| 2023-12-31 | 306.53 | $18.18 | 16.86 |
| 2023-09-30 | 242.13 | $15.35 | 15.78 |
| 2023-06-30 | 240.17 | $12.80 | 18.77 |
| 2023-03-31 | 188.05 | $11.34 | 16.58 |
| 2022-12-31 | 212.41 | $12.43 | 17.09 |
| 2022-09-30 | 157.17 | $11.25 | 13.97 |
| 2022-06-30 | 149.67 | $9.14 | 16.37 |
| 2022-03-31 | 163.59 | $17.98 | 9.10 |
| 2021-12-31 | 217.64 | $26.47 | 8.22 |
| 2021-09-30 | 189.28 | $24.99 | 7.57 |
| 2021-06-30 | 176.63 | $23.78 | 7.43 |
| 2021-03-31 | 164.05 | $23.91 | 6.86 |
| 2020-12-31 | 139.20 | $22.69 | 6.14 |
| 2020-09-30 | 111.75 | $22.14 | 5.05 |
| 2020-06-30 | 93.02 | $20.84 | 4.46 |
| 2020-03-31 | 73.38 | $20.23 | 3.63 |
| 2019-12-31 | 84.06 | $20.14 | 4.17 |
| 2019-09-30 | 84.04 | $19.22 | 4.37 |
| 2019-06-30 | 65.42 | $18.33 | 3.57 |
| 2019-03-31 | 58.97 | $17.41 | 3.39 |
| 2018-12-31 | 52.93 | $16.53 | 3.20 |
| 2018-09-30 | 59.91 | $15.77 | 3.80 |
| 2018-06-30 | 43.00 | $15.19 | 2.83 |
| 2018-03-31 | 34.91 | $14.48 | 2.41 |
| 2017-12-31 | 36.26 | $14.20 | 2.55 |
| 2017-09-30 | 31.90 | $14.71 | 2.17 |
| 2017-06-30 | 29.00 | $15.30 | 1.90 |
| 2017-03-31 | 29.85 | $15.27 | 1.96 |
| 2016-12-31 | 36.07 | $15.02 | 2.40 |
| 2016-09-30 | 29.86 | $15.00 | 1.99 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.568B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $157.813B | 28.64 |
| HCA Healthcare (HCA) | United States | $113.378B | 17.58 |
| CVS Health (CVS) | United States | $95.741B | 11.01 |
| Elevance Health (ELV) | United States | $75.968B | 11.33 |
| Cencora (COR) | United States | $70.528B | 22.74 |
| Natera (NTRA) | United States | $31.966B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.407B | 17.08 |
| DiDi Global (DIDIY) | China | $22.168B | 20.48 |
| Viatris (VTRS) | United States | $15.756B | 5.87 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.545B | 0.00 |
| ICON (ICLR) | Ireland | $14.422B | 14.31 |
| Solventum (SOLV) | United States | $13.340B | 12.95 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $12.190B | 0.00 |
| Revvity (RVTY) | United States | $12.141B | 21.12 |
| Charles River Laboratories (CRL) | United States | $10.494B | 20.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.046B | 0.00 |
| Avantor (AVTR) | United States | $7.548B | 11.53 |
| HealthEquity (HQY) | United States | $7.439B | 27.82 |
| BrightSpring Health Services (BTSG) | United States | $7.302B | 43.54 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.580B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.940B | 39.00 |
| PACS (PACS) | United States | $5.544B | 33.71 |
| Sotera Health (SHC) | United States | $5.199B | 25.07 |
| Alignment Healthcare (ALHC) | United States | $4.532B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.862B | 50.26 |
| Concentras Parent (CON) | United States | $2.839B | 17.72 |
| Organon (OGN) | United States | $2.132B | 2.25 |
| Progyny (PGNY) | United States | $2.087B | 41.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.070B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.914B | 24.67 |
| Pediatrix Medical (MD) | United States | $1.841B | 10.99 |
| Ardent Health (ARDT) | United States | $1.230B | 4.01 |
| Nutex Health (NUTX) | United States | $1.140B | 8.72 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Teladoc Health (TDOC) | United States | $0.953B | 0.00 |
| Omada Health (OMDA) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.774B | 12.67 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.635B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.616B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 24.48 |
| SBC Medicals (SBC) | United States | $0.505B | 9.28 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.408B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.356B | 5.73 |
| Agilon Health (AGL) | United States | $0.343B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.294B | 0.00 |
| So-Young (SY) | China | $0.284B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Pomdoctor - (POM) | China | $0.025B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.03 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |